+DayWeekMonth−
Thursday · Nov 5, 2026 · Health Digest · public-health

WHO adds two Bundibugyo-specific Ebola vaccine candidates to Congo trial as cholera also surges

WHO said the candidates were recommended by its independent Technical Advisory Group on Candidate Vaccines Prioritization and will enter the Tumaini multi-vaccine trial after national approvals, according to UN News. The trial, launched on October 23 in Bunia, the capital of Ituri province, already tests Ervebo, a vaccine for the Zaire species, and uses ring vaccination of contacts of confirmed cases. UN News said it will be the first time vaccines designed for Bundibugyo virus are evaluated during an outbreak.

As of November 1, the outbreak had more than 10,500 confirmed cases and 5,126 deaths, according to UN News. Director-General Tedros Adhanom Ghebreyesus also said Congo faces its worst cholera outbreak in decades, with more than 60,000 cases and 1,800 deaths this year, KUNA reported.

Why it matters: The outbreak is the largest in Congo's history, according to UN News, and the trial is the first test of Bundibugyo-specific vaccines during an outbreak. Tedros said vaccines do not replace detection, contact tracing, isolation and better water and sanitation, according to KUNA.

References

  1. Two new candidate vaccines to join Ebola trial as treatment research advances
    WHO · who.int · 2026-11-05
  2. Two new Ebola vaccines to join DR Congo clinical trial
    UN News · news.un.org · 2026-11-05
  3. WHO warns of worsening health crisis in DR Congo as Ebola cases top 10,000 (KUNA)
    Kuwait Times · kuwaittimes.com · 2026-11-05